InMed Pharmaceuticals (INM) Q1 2026 Earnings

May 6Confirmed
Q2 2025
Q4 2025
Q1 2026
Q1 2026
-1.94
-1.52
-1.11
-0.69

Details

Expected EPS
N/A
Actual EPS
-0.69
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨InMed Pharmaceuticals⁩ (⁦INM⁩) has reported earnings of ⁦-0.69⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts